Results 121 to 130 of about 57,297 (272)
Community participation agreements: a model for welfare reform from community-based research [PDF]
Summary In its June 2001 budget, the Federal Government announced a new framework for welfare reform, Australians Working Together. One component of the framework is the proposed development of Community Participation Agreements in remote Indigenous ...
Diane Smith
core +1 more source
Plasma neuropeptide Y levels in medication naive adolescents with major depressive disorder
Objective: Neuropeptide Y (NPY) has been implicated in pathophysiology of anxiety and depression. It was proposed that NPY counteracts corticotropin-releasing factor-mediated stress effects to maintain emotional regulation.
Medine Yazici Gulec +5 more
doaj
Influence of Asymmetry on the Molecular and Electronic Structures of μ‐Oxo Diferric Complexes
The 6‐methyl substituents at the pyridines (shown in red) enforce longer MNpy bonds than without them (shown in green).The asymmetric dinucleating susanH2Me2 is used for the synthesis of a μ‐oxo diferric complex. Comparison to the two symmetric complexes of susan and susan6−Me shows a strong effect on the redox potentials.
Sören Jansen +4 more
wiley +1 more source
GH-Releasing Peptide-2 Increases Fat Mass in Mice Lacking NPY: Indication for a Crucial Mediating Role of Hypothalamic Agouti-Related Protein [PDF]
M. Tschöp
openalex +1 more source
Vildagliptin and omarigliptin, dipeptidyl peptidase‐4 (DPP‐4) inhibitors, have differential effects on bone cells. Although vildagliptin improved the bone microstructure of high‐fat diet‐fed rats, it was unable to downregulate osteoclastogenesis or the expression of key osteoclast transcripts.
Ratchaneevan Aeimlapa +11 more
wiley +1 more source
Evidence Suggesting That Galanin (GAL), Melanin-Concentrating Hormone (MCH), Neurotensin (NT), Proopiomelanocortin (POMC) and Neuropeptide Y (NPY) Are Targets of Leptin Signaling in the Hypothalamus [PDF]
A. Sahu
openalex +1 more source
This systematic review synthesizes evidence from published studies, GWAS and grey literature (patents) to show that CAMK1D is implicated in diabetes, obesity, insulin resistance and altered feeding behaviours, with diagnostic potential and mechanistic relevance through regulatory binding and tissue‐specific effects.
Livio Tarchi +13 more
wiley +1 more source
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo +11 more
wiley +1 more source
Sympathetic NPY controls glucose homeostasis, cold tolerance, and cardiovascular functions in mice
Summary: Neuropeptide Y (NPY) is best known for its effects in the brain as an orexigenic and anxiolytic agent and in reducing energy expenditure. NPY is also co-expressed with norepinephrine (NE) in sympathetic neurons.
Raniki Kumari +8 more
doaj +1 more source

